National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 10) (PB 106 of 2017) (Cth)

PB 106 of 2017

National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 10)

National Health Act 1953

I, SEAN LANE, Assistant Secretary (Acting), Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated      14    December 2017

SEAN LANE

Assistant Secretary (Acting)

Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 10).

(2)   This Determination may also be cited as PB 106 of 2017.

1. Commencement

This Determination commences on 1 January 2018.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Albendazole

Insert

Alectinib

[2]     Schedule 1, after item dealing with Carbomer 974

Insert

Carfilzomib